RadioPharm Theranostics, page-2

  1. 2,370 Posts.
    lightbulb Created with Sketch. 45
    http://www.radiopharmtheranostics.comIndustryBiotechnologyRadioPharm Theranostics


    ! Media Release:RADIOPHARM THERANOSTICS RAISES A$20M SEED CAPITAL FOR WORLD-CLASS NUCLEAR MEDICINE TECHNOLOGIES

    We are pleased to announce we have raised A$20 million via convertible notes through Bell Potter and Baker Young, to progress a highly prospective portfolio of radiopharmaceutical assets for diagnostic and therapeutic applications.

    Our Executive Chairman and Founder, Paul Hopper, has commented:

    “I am thrilled to be able to combine a range of outstanding assets with highly credentialled management in a sector that has attracted an intense level of interest in recent years.

    The funds we’ve been able to bring in as part of this capital raising will allow us to further develop our portfolio unimpeded, while building out the executive team as we consider additional funding options moving forward.

    I’d like to thank our new shareholders for their support and look forward to delivering value to our investors while ultimately commercialising radiopharmaceutical technologies that improves patient outcomes.”

    Key executives have been secured including Prof David Mozley as CMO and Dr Thom Tulip as CTO, with CEO announcement in the near term.
    Last edited by Jazz6868: 17/08/21
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.